Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127982661 | 12798266 | 1 | I | 20110429 | 20110607 | 20160930 | 20160930 | EXP | US-ROCHE-782575 | ROCHE | 57.00 | YR | F | Y | 85.00000 | KG | 20160930 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127982661 | 12798266 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | OVER 30-90MIN ON DAY 1. LAST DATE PRIOR TO SAE 22 APR 2011, DRG WITHDRAWN | U | 125085 | 15 | MG/KG | SOLUTION FOR INFUSION | ||||||
| 127982661 | 12798266 | 2 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1479 | MG | ||||||||
| 127982661 | 12798266 | 3 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1479 | MG | ||||||||
| 127982661 | 12798266 | 4 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1479 | MG | ||||||||
| 127982661 | 12798266 | 5 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1252 | MG | ||||||||
| 127982661 | 12798266 | 6 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1479 | MG | ||||||||
| 127982661 | 12798266 | 7 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1252 | MG | ||||||||
| 127982661 | 12798266 | 8 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1252 | MG | ||||||||
| 127982661 | 12798266 | 9 | SS | ENOXAPARIN SODIUM. | ENOXAPARIN SODIUM | 1 | Unknown | WITH HELD | U | 0 | |||||||||
| 127982661 | 12798266 | 10 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | OVER 3 HRS ON DAY 1.LAST DATE PRIOR TO SAE 22 APR 2011 | U | 0 | 175 | MG/M**2 | |||||||
| 127982661 | 12798266 | 11 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | AUC: 6, OVER 30 MIN ON DAY 1. LAST DATE PRIOR TO SAE 22 APR 2011 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127982661 | 12798266 | 1 | Endometrial cancer |
| 127982661 | 12798266 | 9 | Endometrial cancer |
| 127982661 | 12798266 | 10 | Endometrial cancer |
| 127982661 | 12798266 | 11 | Endometrial cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127982661 | 12798266 | OT |
| 127982661 | 12798266 | HO |
| 127982661 | 12798266 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127982661 | 12798266 | Acute kidney injury | |
| 127982661 | 12798266 | Anaemia | |
| 127982661 | 12798266 | Bone pain | |
| 127982661 | 12798266 | Haematoma | |
| 127982661 | 12798266 | Neutrophil count decreased | |
| 127982661 | 12798266 | Platelet count decreased | |
| 127982661 | 12798266 | Syncope | |
| 127982661 | 12798266 | White blood cell count decreased | |
| 127982661 | 12798266 | Wound infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127982661 | 12798266 | 10 | 20110217 | 0 | ||
| 127982661 | 12798266 | 11 | 20110217 | 0 |